Cardinal Health, Inc. Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year
Cardinal Health, Inc. (CAH) had Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year of $193.00 million as of 2025-12-31, per its 10-Q filed 2026-02-05.
Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear · last filed 2026-02-05
- 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $193.00M.
- 2025-09-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $269.00M.
- 2025-03-31: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $82.00M.
- 2024-12-31: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $144.00M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year |
|---|---|
| 2025-12-31 | $193.00M 10-Q · filed 2026-02-05 |
| 2025-09-30 | $269.00M 10-Q · filed 2025-10-30 |
| 2025-03-31 | $82.00M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $144.00M 10-Q · filed 2025-01-30 |
| 2024-09-30 | $200.00M 10-Q · filed 2024-11-01 |
| 2024-03-31 | $69.00M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $127.00M 10-Q · filed 2024-02-01 |
| 2023-09-30 | $190.00M 10-Q · filed 2023-11-03 |
| 2023-03-31 | $71.00M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $147.00M 10-Q · filed 2023-02-02 |
| 2022-09-30 | $212.00M 10-Q · filed 2022-11-04 |
| 2022-03-31 | $78.00M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $157.00M 10-Q · filed 2022-02-03 |
| 2021-09-30 | $236.00M 10-Q · filed 2021-11-09 |
| 2021-03-31 | $91.00M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $217.00M 10-Q · filed 2021-02-05 |
| 2020-09-30 | $333.00M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $442.00M 10-K · filed 2020-08-13 |
| 2020-03-31 | $134.00M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $258.00M 10-Q · filed 2020-02-06 |
| 2019-09-30 | $382.00M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $509.00M 10-K · filed 2019-08-20 |
| 2019-03-31 | $133.00M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $264.00M 10-Q · filed 2019-02-07 |
| 2018-09-30 | $396.00M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $529.00M 10-K · filed 2018-08-22 |
| 2018-03-31 | $139.00M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $289.00M 10-Q · filed 2018-02-08 |
| 2017-09-30 | $444.00M 10-Q · filed 2017-11-07 |
| 2014-03-31 | $46.00M 10-Q · filed 2014-05-06 |
| 2013-12-31 | $92.00M 10-Q · filed 2014-02-06 |
| 2013-09-30 | $136.00M 10-Q · filed 2013-11-07 |
| 2013-03-31 | $48.00M 10-Q · filed 2013-05-08 |
| 2012-12-31 | $42.00M 10-Q · filed 2013-02-06 |
| 2012-09-30 | $65.00M 10-Q · filed 2012-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B |